Voloridge Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.7M | Buy |
+1,053,798
| New | +$7.7M | 0.03% | 630 |
|
|
2023
Q4 | – | Sell |
-42,213
| Closed | -$519K | – | 1363 |
|
|
2023
Q3 | $519K | Sell |
42,213
-210,231
| -83% | -$2.59M | ﹤0.01% | 1207 |
|
|
2023
Q2 | $4.06M | Sell |
252,444
-135,621
| -35% | -$2.18M | 0.02% | 748 |
|
|
2023
Q1 | $6.76M | Sell |
388,065
-72,225
| -16% | -$1.26M | 0.03% | 577 |
|
|
2022
Q4 | $4.25M | Sell |
460,290
-203,592
| -31% | -$1.88M | 0.02% | 702 |
|
|
2022
Q3 | $5.72M | Sell |
663,882
-419,627
| -39% | -$3.61M | 0.03% | 610 |
|
|
2022
Q2 | $8.83M | Buy |
1,083,509
+524,580
| +94% | +$4.28M | 0.05% | 487 |
|
|
2022
Q1 | $6.79M | Buy |
+558,929
| New | +$6.79M | 0.04% | 531 |
|
|
2021
Q3 | – | Sell |
-51,501
| Closed | -$2.33M | – | 1787 |
|
|
2021
Q2 | $2.33M | Buy |
51,501
+47,129
| +1,078% | +$2.13M | 0.02% | 937 |
|
|
2021
Q1 | $211K | Sell |
4,372
-15,159
| -78% | -$732K | ﹤0.01% | 1315 |
|
|
2020
Q4 | $1.05M | Sell |
19,531
-63,360
| -76% | -$3.41M | 0.01% | 954 |
|
|
2020
Q3 | $3.06M | Buy |
82,891
+70,557
| +572% | +$2.6M | 0.03% | 580 |
|
|
2020
Q2 | $382K | Sell |
12,334
-110,500
| -90% | -$3.42M | ﹤0.01% | 1084 |
|
|
2020
Q1 | $3.39M | Sell |
122,834
-40,621
| -25% | -$1.12M | 0.1% | 226 |
|
|
2019
Q4 | $4.78M | Buy |
163,455
+62,799
| +62% | +$1.84M | 0.09% | 278 |
|
|
2019
Q3 | $1.93M | Buy |
100,656
+7,938
| +9% | +$152K | 0.03% | 460 |
|
|
2019
Q2 | $2.03M | Buy |
92,718
+18,549
| +25% | +$407K | 0.06% | 320 |
|
|
2019
Q1 | $1.52M | Buy |
+74,169
| New | +$1.52M | 0.05% | 357 |
|